Drugs / V-Boost
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03916757 | Apr 2019 → Apr 2020 | brain glioma, glioblastoma | Immunitor LLC | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V-Boost | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03916757 ↗ |
| Modality | Vaccine | “V-Boost immunotherapeutic vaccine” NCT03916757 ↗ |
| Route | Oral | “daily oral administration” NCT03916757 ↗ |